The price of pharmaceuticals will likely go up soon, and generics are poised to be hit the hardest.

Johnson & Johnson JNJ and Pfizer PFE are two of the world’s largest pharmaceutical companies with diversified healthcare ...

Stocks recently featured in the blog include: Johnson & Johnson JNJ and Pfizer PFE. Here are highlights from Thursday’s Analyst Blog: J&J vs. Pfizer: Which Big Pharma Stock Is the Better Buy Today?

Johnson & Johnson and Pfizer both highlighted new data with BCMA-targeting bispecific antibodies in patients with relapsed or refractory multiple myeloma (RRMM) at ASCO, previewing a future ...

The Centers for Medicare and Medicaid Services estimates U.S. health care spending will grow 5.6% annually through 2032, ...

Johnson & Johnson has laid out plans to raise U.S. investments by 25% to more than $55 billion over the next four years, as a ...

Pfizer, Amgen, and Johnson & Johnson were among other pharma stocks that dropped at the US market open on April 9 amid ...

While Trump has been wildly inconsistent on his plans for reciprocal tariffs, levies on imported pharmaceuticals appear to be ...

Pharmaceutical stocks tumble as Trump announces imminent “major tariff” on imported drugs. Pfizer, Merck, and Johnson & Johnson shares drop over 4%, dragging the broader S&P 500 lower.

Officials at the Department of Health and Human Services have struggled to find records belonging to Dr. Tom Shimabukuro, the director of the CDC’s Immunization Safety Office.